Inspirna (formerly known as Rgenix) is a biopharmaceutical company developing cancer drugs. It uses a proprietary drug discovery platform to develop therapies for cancer patients. The company's lead therapy is a small molecule immunotherapy that blocks the ability of tumors to evade the immune system.